Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: Incidence and risk factors*

@article{Dnser2003IschemicSL,
  title={Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: Incidence and risk factors*},
  author={Martin W D{\"u}nser and Andreas J. Mayr and Andreas T{\"u}r and Werner Pajk and Friesenecker Barbara and Hans Knotzer and Hanno Ulmer and Walter R. Hasibeder},
  journal={Critical Care Medicine},
  year={2003},
  volume={31},
  pages={1394-1398}
}
ObjectiveTo report on the incidence and risk factors associated with the development of ischemic skin lesions (ISL) in critically ill patients with catecholamine-resistant vasodilatory shock treated with a continuous infusion of arginine-vasopressin (AVP). DesignRetrospective analysis. SettingTwelve-bed general and surgical intensive care unit in a university hospital. PatientsA total of 63 critically ill patients with catecholamine-resistant vasodilatory shock. InterventionsContinuous AVP… Expand
Arginine vasopressin in 316 patients with advanced vasodilatory shock*
TLDR
Supplementary AVP infusion improved cardiocirculatory function in advanced vasodilatory shock, but an increase in liver enzymes and bilirubin, and a decrease in platelet count occurred during AVP therapy, particularly during simultaneous hemofiltration. Expand
The role of the microcirculation in the etiology of ischemic skin and mouth lesions during vasopressin therapy
TLDR
The authors agree that the cause of microcirculatory alterations during sepsis is multifactorial, and that generalized conclusions about the effect of vasopressin on the microcirculation should be made with restraint; the lack of invasive cardiac output and mixed-venous saturation measurements is a limitation of the study. Expand
Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome
TLDR
Supplementary AVP infusion in patients with advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome did not compromise cutaneous reactive hyperaemia and flowmotion when compared with norepinephrine infusion alone. Expand
Effects of Continuous Vasopressin Infusion in Patients with Septic Shock
TLDR
Vasopressin infusion was effective in increasing MAP and reducing heart rate while decreasing the dopamine dosage in patients with septic shock, and Comparative studies with catecholamine vasopressors are needed to define the optimal role of vasopressing in septicshock therapy. Expand
Ischemic skin lesions and microcirculatory collapse during vasopressin therapy: a possible role of the microcirculation?
TLDR
The data indicate that it is not the choice of vasopressor applied, but other factors, that cause a collapse of capillary perfusion and end-organ ischemia in severe cardiovascular failure, and may indicate that adequate cardiac output is maintained by both volume and inotropic therapy, the cardiac index is not associated with the occurrence of ischemic skin lesions during AVP therapy. Expand
Vasopressin analogues in the treatment of shock states: potential pitfalls.
TLDR
Previous data on adverse effects related to the therapy with vasopressin analogues are summarized, continuous TP infusion appears to be superior to bolus infusion and potential options to prevent such adverse events are discussed. Expand
Angiotensin II and Vasopressin for Vasodilatory Shock: A Critical Appraisal of Catecholamine-Sparing Strategies
TLDR
This narrative review is to provide insight into the historical use of noncatecholamine vasopressors and to compare and contrast their unique modes of action, physiologic rationale for administration, efficacy, and safety profiles. Expand
Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series
TLDR
Vasopressin loading may predict responses to its continuous administration in septic shock patients, and outcomes including mortality were not significantly different between responders and non-responders. Expand
Skin Necrosis after High Dose Vasopressor Infusion in Septic Shock - Two Case Reports -
TLDR
2 cases of severe skin necrosis after high dose vasopressor infusion to maintain the recommended MAP in septic shock are reported, which required amputations in both cases. Expand
Effects of Low Dose Vasopressin in Catecholamine Resistant Septic Shock.
TLDR
Low dose vasopressin at the rate of 0.04 unit/minute is an effective vasopressor in adult patients with catecholamine resistant septic shock and improvement in systolic and mean arterial pressure continued throughout the 24-hour period. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 35 REFERENCES
The Role of Vasopressin in the Treatment of Vasodilation in Shock States
TLDR
Vasopressin may be a reasonable alternative for patients in vasodilatory shock, however, larger-scale controlled clinical trials are warranted before its routine use can be recommended. Expand
The Effects of Vasopressin on Systemic Hemodynamics in Catecholamine-Resistant Septic and Postcardiotomy Shock: A Retrospective Analysis
TLDR
During AVP infusion, a significant increase in liver enzymes and total bilirubin concentration and a significant decrease in platelet count occurred and arginine vasopressin was effective in reversing systemic hypotension. Expand
Low-dose vasopressin in the treatment of vasodilatory septic shock.
TLDR
A VP infusion improved arterial pressure and permitted the withdrawal of catecholamine vasopressors and is a useful agent in the treatment of refractory septic shock. Expand
Prostanoid Drug Therapy for Peripheral Arterial Occlusive Disease—The European Experience
TLDR
In the last 12 years the results of properly controlled randomized trials involving patients with chronic limb ischaemia have been carried out in approximately 2000 patients in Europe, the largest number were entered into trials using the prostacyclin analogue iloprost. Expand
Tissue oxygenation in hypovolemic shock.
TLDR
The degree of bowel ischemia, clinically inaccessible for quantitation, is paralleled by subcutaneous TPO2, which provides information about oxygen availability in shock and resuscitation not available from traditional parameters of oxygen transport. Expand
Extremity amputation: disseminated intravascular coagulation syndrome.
TLDR
DIC is a major pathophysiologic mechanism responsible for peripheral gangrene following systemic infection and is the key clinical features of this syndrome. Expand
Symmetrical peripheral gangrene due to disseminated intravascular coagulation.
TLDR
A 50-year-old white man developed fevers, chills, shortness of breath, and a cough that produced green sputum that progressed rapidly to gangrene involving the hands, feet, tip of the nose, ears, and posterior scalp area, which was transferred to Mayo Clinic for consideration of amputation of the gangrenous areas. Expand
Dopamine-associated symmetric peripheral gangrene.
TLDR
2 cases of dopamine hydrochloride— associated SPG seen over the course of 9 months are presented, including a 65-year-old white man with recurrent metastatic transitional cell carcinoma of the bladder presented with vomiting, diarrhea, and a 7-kg weight loss. Expand
The effect of triglycyl-lysine-vasopressin (terlipressin INN, Glypressin) on skin blood flow, measured with laser Doppler flowmetry, thermography and plethysmography. A dose-response study.
TLDR
The study supports earlier findings and suggests a dose level of TGLVP for the use in excision of burns, which is less sensitive for detecting effects of T GLVP than laser Doppler flowmetry. Expand
Multiple-organ failure. Generalized autodestructive inflammation?
TLDR
It is concluded that sepsis is probably not the essential cause of MOF, and an alternative hypothesis is presented involving massive activation of inflammatory mediators by severe tissue trauma or intra-abdominal sepsi, resulting in systemic damage to vascular endothelia, permeability edema, and impaired oxygen availability to the mitochondria despite adequate arterial oxygen transport. Expand
...
1
2
3
4
...